-
Trend Study on In-force Medical Business in China
By Chen Zhang and Xiaotian Yu Apr 26, 2022 English
“Million Medical Insurance”1 (百万医疗 in Chinese) is the fastest-growing commercial health insurance product in recent years, and its experience monitoring has raised keen concerns for Chinese insurers. It is well-known that medical inflation, portfolio...
Read More -
Critical Illness in Asia – Product Evolution and its Implications
By Orchis Li Apr 07, 2022 English
Highlights from the Gen Re Dread Disease Survey We started offering Critical Illness (CI) products in the late 1980s and early 1990s, covering just seven diseases. This quickly increased to around 30 conditions and then more than 50 by the late 1990s. In...
Read More -
Underwriting 5.0 – Insights into Client Behavior
By Dr. (Celia) Ying Zhang and Weibo Chen Mar 29, 2022 English
At the end of our paper “Underwriting in China – A Digital Transformation”, we opined that the ability to collect structured underwriting data was an important spin-off benefit of online life insurance application and automated underwriting processes. Here...
Read More -
Y Invest in Gen Z?
By Emma Matteson Jan 11, 2022 English
An underinvestment in attracting new talent since the early 2000s, an acceleration in baby boomers exiting the workforce, and the global COVID‑19 pandemic have created the perfect storm for a talent crisis in the insurance industry. The skills shortage...
Read More
